A5029484131- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Venous Thromboembolism Diagnosis and Management
- Pulmonary Hypertension Research and Treatments
- Diabetes and associated disorders
- COVID-19 and healthcare impacts
- Vascular Anomalies and Treatments
- Diverse Scientific Research Studies
- Organ Donation and Transplantation
- IgG4-Related and Inflammatory Diseases
- COVID-19 Impact on Reproduction
- Adipokines, Inflammation, and Metabolic Diseases
- Liver Disease Diagnosis and Treatment
- Sepsis Diagnosis and Treatment
- Gastrointestinal disorders and treatments
- Cardiovascular Disease and Adiposity
- Renal and Vascular Pathologies
- Ultrasound in Clinical Applications
- Renal Diseases and Glomerulopathies
- Cardiac Valve Diseases and Treatments
- Malaria Research and Control
- SARS-CoV-2 and COVID-19 Research
- Pancreatitis Pathology and Treatment
- Artificial Intelligence in Healthcare
University of Michigan
2021-2024
Hôpital Edouard Herriot
1990-1991
Communauté urbaine de Lyon
1991
Société Française de Médecine Vasculaire
1991
OBJECTIVE Diabetes mellitus (DM) is a major risk factor for severe coronavirus disease 2019 (COVID-19) reasons that are unclear. RESEARCH DESIGN AND METHODS We leveraged the International Study of Inflammation in COVID-19 (ISIC), multicenter observational study 2,044 patients hospitalized with COVID-19, to characterize impact DM on in-hospital outcomes and assess contribution inflammation hyperglycemia attributed DM. measured biomarkers collected at hospital admission glucose levels insulin...
Abstract Severe coronavirus disease 2019 (COVID‐19) is a hyperinflammatory syndrome. The biomarkers of inflammation best suited to triage patients with COVID‐19 are unknown. We conducted prospective multicenter observational study adult hospitalized specifically for from February 1, 2020 October 19, 2022. Biomarkers measured included soluble urokinase plasminogen activator receptor (suPAR), C‐reactive protein, interleukin‐6, procalcitonin, ferritin, and D‐dimer. In‐hospital outcomes examined...
Background: Preexisting cardiovascular disease (CVD) is perceived as a risk factor for poor outcomes in patients with COVID-19. We sought to determine whether CVD associated in-hospital death and events critically ill Methods: This study used data from multicenter cohort of adults laboratory-confirmed COVID-19 admitted intensive care units at 68 centers across the United States March 1 July 1, 2020. The primary exposure was CVD, defined preexisting coronary artery disease, congestive heart...
Background Use of angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers (ACEi/ARB) is thought to affect COVID‐19 through modulating levels 2, the cell entry for SARS‐CoV2. We sought assess association between ACEi/ARB, biomarkers inflammation, outcomes in patients hospitalized COVID‐19. Methods Results leveraged ISIC (International Study Inflammation COVID‐19), identified admitted symptomatic February 1, 2020 June 2021 COVID‐19, examined in‐hospital ACEi/ARB use...
Background Venous thromboembolism (VTE) contributes significantly to COVID-19 morbidity and mortality. The urokinase receptor system is involved in the regulation of coagulation. Levels soluble plasminogen activator (suPAR) reflect hyperinflammation are strongly predictive outcomes COVID-19. Whether suPAR levels identify patients with at risk for VTE unclear. Methods Results We leveraged a multinational observational study hospitalized D-dimer measured on admission. In 1960 (mean age, 58...
Catheter-based interventions have emerged for both acute and chronic pulmonary thromboembolic disease. With this development the need segmental cannulation, anatomic understanding of arterial branch origination is important. We aim to describe prevalence different patterns.
<b>Objective: </b>Diabetes mellitus (DM) is a major risk factor for severe coronavirus disease 2019 (COVID-19) reasons that are unclear. <p><b>Research Design and Methods: </b>We leveraged The International Study of Inflammation in COVID-19, multicenter observational study 2,044 patients hospitalized with to characterize the impact DM on in-hospital outcomes assess contribution inflammation hyperglycemia attributed DM. We measured biomarkers collected at...
<b>Objective: </b>Diabetes mellitus (DM) is a major risk factor for severe coronavirus disease 2019 (COVID-19) reasons that are unclear. <p><b>Research Design and Methods: </b>We leveraged The International Study of Inflammation in COVID-19, multicenter observational study 2,044 patients hospitalized with to characterize the impact DM on in-hospital outcomes assess contribution inflammation hyperglycemia attributed DM. We measured biomarkers collected at...